U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710599) titled 'LKB1 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer: A Retrospective Cohort Study' on July 07.
Brief Summary: The goal of this observational study is to investigate whether LKB1 alterations can serve as a clinically meaningful biomarker for predicting therapeutic response and survival outcomes in patients with non-small cell lung cancer (NSCLC), and to determine how LKB1 mutation status together with co-occurring genomic alterations influences treatment sensitivity across different therapeutic strategies.
This study will include adult patients diagnosed with NSCLC who underwent surgical resection or tumor biopsy, ge...